Xuesong Mike Liu - Concepedia

Author

Xuesong Mike Liu

Also Known As

Xuesong Mike Liu

Publications

126

Citations

H-Index

Concepts

All Affiliations

Xuesong Mike Liu is an author at Incyte (United States) specializing in medicine, tumor biology, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	77
2	Cell Biology	4	4	77
3	Health Sciences	2	2	51
4	Immunology	2	2	26
5	Natural Sciences	1	1	15

Xuesong Mike Liu

Publications

126

Citations

H-Index

Page 1

	Year	Citations
The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies Matthew C. Stubbs, Timothy C. Burn, Richard Sparks, Clinical Cancer Research	2018	49
Abstract 4712: Discovery of INCB059872, a novel FAD-directed LSD1 inhibitor that is effective in preclinical models of human and murine AML Sang‐Hyun Lee, Matthew C. Stubbs, Xuesong Mike Liu, Cancer Research Histone ModificationsDrug TargetMixed-phenotype Acute LeukemiaEpigenetic ChangeMurine Aml	2016	30
Abstract 4704: The evaluation of INCB059872, an FAD-directed inhibitor of LSD1, in preclinical models of human small cell lung cancer Sang‐Hyun Lee, Xuesong Mike Liu, Melody Diamond, Cancer Research Histone ModificationsEpigenetic ChangeMethylation MarksCancer BiologyEpigenetics	2016	21
Abstract 3523: Discovery of a novel BET inhibitor INCB054329 Phillip CC Liu, Xuesong Mike Liu, Matthew C. Stubbs, Cancer Research ImmunologyMolecular BiologyImmunotherapyCancer BiologyTumor Biology	2015	15
Abstract 5071: Preclinical characterization of the potent and selective BET inhibitor INCB057643 in models of hematologic malignancies Matthew C. Stubbs, Thomas Maduskuie, Timothy C. Burn, Cancer Research ImmunologyPathologyCell CycleBet InhibitorsCancer Biology	2017	11

Page 1